News

Chart Industries' long lead times and multiyear projects shield it from short-term political disruptions. Read why GTLS stock ...
Q4 2024 Earnings Call Transcript May 29, 2025 Roivant Sciences Ltd. misses on earnings expectations. Reported EPS is $-0.22 ...
Opus 4 is Anthropic’s new crown jewel, hailed by the company as its most powerful effort yet and the “world’s best coding ...
A flow chart for patient management in the control arm is provided ... The trial details documented here are consistent with the TAPPS Trial protocol V.6 (date: 06/10/2014). A summary of the trial ...
Enterprise Products Partners offers tax-efficient income, consistent growth, and a strong asset moat. Learn why EPD stock is ...
SAN DIEGO--(BUSINESS WIRE)--Scientist.com, the leading R&D procurement platform for the life sciences, today integrated Trial Insights™—its real‑time clinical‑trial analytics tool—into ...
It’s been a month since testimony began in Karen Read’s second trial for the murder of John O’Keefe, and the new trial has brought a notable change in presentation. “I mean, I didn’t ...
Nearly half of sequencing data labeled as endometriosis lacks true disease representation, highlighting the urgent need for more diverse and accurate tissue sampling to advance research in this ...
Long-simmering tension between Silicon Valley and the press that covers it is surfacing during the Federal Trade Commission’s antitrust trial against Meta. The exchange resurfaced years-old ...
That is the central question posed to a federal jury Monday on the first day of testimony in Sean “Diddy” Combs’ racketeering and sex trafficking trial in New York City. The criminal trial ...